Activity | Compound | |||||||
---|---|---|---|---|---|---|---|---|
FB1 | FB2 | FB3 | FB4 | FB5 | FB6 | FB7 | FB8 | |
Lipophilicity (Consensus Log Po/w) | 3.06 | 2.6 | 1.34 | 0.84 | 0.83 | 2.68 | 1.44 | 0.93 |
GI absorption | High | High | High | Low | Low | High | Low | Low |
BBB permeant | Yes | Yes | No | No | No | Yes | No | No |
Pgp substrate | No | No | Yes | Yes | Yes | No | Yes | Yes |
CYP1A2 inhibitor | Yes | Yes | No | No | No | Yes | No | No |
CYP2C19 inhibitor | Yes | No | No | No | No | No | No | No |
CYP2C9 inhibitor | Yes | Yes | No | No | No | Yes | No | No |
CYP2D6 inhibitor | No | No | No | No | No | No | No | No |
CYP3A4 inhibitor | Yes | Yes | No | No | No | Yes | No | No |
log Kp (cm/s) | − 5.31 | − 5.46 | − 7.83 | − 8.18 | − 8.18 | − 5.67 | − 8.03 | − 8.38 |
TPSA [Å2] | 55.76 | 66.76 | 134.91 | 155.14 | 155.14 | 75.99 | 144.14 | 164.37 |
Bioavailability Score | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 |
Caco2 | 3.3024 | 1.5977 | 1.2027 | 0.9497 | 1.254 | 1.3496 | 0.5654 | 1.1716 |
HIA | 95.582 | 92.833 | 83.525 | 68.065 | 68.065 | 93.199 | 81.663 | 63.994 |